The company’s current development pipeline focuses on the metastatic mechanisms, oncogenes, and key regulators in sumoylation, neddylation, ubiquitination, and PI3 kinase cancer pathways.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer